Research keywords (11):
protein domain
, RNA
, alternative splicing
, protein interaction
, database
, ligand-binding site
, functional site
, protein structure
, protein module
, homology modeling
, RNA editing
Research theme for competitive and other funds (8):
2022 - 2025 Can a combination of cofactor-binding prediction and experimental validation identify uncharacterized enzymes?
2019 - 2022 Development of a prediction method for cofactors binding to uncharacterized enzymes using feedback from experimental validations
2015 - 2018 Development of a method for predicting functional sites in function-unknown splicing isoforms
2011 - 2012 Development of a estimation method for difference of functional sites among splicing isoforms
2006 - 2009 Studying Function of Alternative Splicing Products Based on Protein Structure Modeling
2003 - 2004 タンパク質間相互作用の解析と予測法の開発
2001 - 2001 タンパク質のドメイン自動同定法の開発とそのゲノム情報解析への適用
Show all
Papers (35):
Yunhao Zhu, Kaishin Shigeyoshi, Yumiko Hayakawa, Sae Fujiwara, Masamichi Kishida, Hitoshi Ohki, Tomohisa Horibe, Masafumi Shionyu, Tamio Mizukami, Makoto Hasegawa. Acceleration of Protein Degradation by 20S Proteasome-Binding Peptides Generated by In Vitro Artificial Evolution. International Journal of Molecular Sciences. 2023. 24. 24. 17486-17486
Kaoru Nomura, Shoko Mori, Kohki Fujikawa, Tsukiho Osawa, Shugo Tsuda, Kumiko Yoshizawa-Kumagaye, Shun Masuda, Hideki Nishio, Taku Yoshiya, Takao Yoda, et al. Role of a bacterial glycolipid in Sec-independent membrane protein insertion. Scientific reports. 2022. 12. 1. 12231-12231
Shoko Mori, Kaoru Nomura, Kohki Fujikawa, Tsukiho Osawa, Masafumi Shionyu, Takao Yoda, Tsuyoshi Shirai, Shugo Tsuda, Kumiko Yoshizawa-Kumagaye, Shun Masuda, et al. Intermolecular Interactions between a Membrane Protein and a Glycolipid Essential for Membrane Protein Integration. ACS chemical biology. 2022. 17. 3. 609-618
Atsushi Hijikata, Clara Shionyu-Mitsuyama, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Takatsugu Hirokawa, Shogo Nakajima, Koichi Watashi, Tsuyoshi Shirai. Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2. FEBS open bio. 2022. 12. 1. 285-294
Atsushi Hijikata, Clara Shionyu, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Tsuyoshi Shirai. Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins. Biophysics and physicobiology. 2021. 18. 226-240